Silva Paul M Insider Trades

Insider Trading History

Track insider trading activity for Silva Paul M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Rapport Therapeutics
Rapport Therapeutics RAPP
Director
Holding Value $630k 15,200 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$535k 15,200 shares
$35.21
$41.46
Nurix Therapeutics
Nurix Therapeutics NRIX
Director
Holding Value $745k 31,250 shares
Last Trade
May 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$496k 31,250 shares
$15.86
$23.85
Rapport Therapeutics
Rapport Therapeutics RAPP
Director
Holding Value $453k 10,925 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 10,925 shares
$10.95
$41.46
Nurix Therapeutics
Nurix Therapeutics NRIX
Director
Holding Value $596k 25,000 shares
Last Trade
May 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$238k 25,000 shares
$9.51
$23.85
Rapport Therapeutics
Rapport Therapeutics RAPP
Director
Holding Value $1.23M 29,756 shares
Last Trade
Nov 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$800k 29,756 shares
$26.90
$41.46
Nurix Therapeutics
Nurix Therapeutics NRIX
Director
Holding Value $596k 25,000 shares
Last Trade
May 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$405k 25,000 shares
$16.19
$23.85
Nurix Therapeutics
Nurix Therapeutics NRIX
Director
Holding Value $596k 25,000 shares
Last Trade
May 04, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$236k 25,000 shares
$9.44
$23.85
Nurix Therapeutics
Nurix Therapeutics NRIX
Director
Holding Value $417k 17,500 shares
Last Trade
May 05, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$182k 17,500 shares
$10.39
$23.85
Nurix Therapeutics
Nurix Therapeutics NRIX
Director
Holding Value $835k 35,000 shares
Last Trade
Oct 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.09M 35,000 shares
$31.24
$23.85
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
SVP & Chief Accounting Officer
Holding Value $5.55M 11,640 shares
Last Trade
Mar 01, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$588k 2,782 shares
$211.45
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
SVP & Chief Accounting Officer
Holding Value $6.04M 12,666 shares
Last Trade
Feb 26, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$471k 2,218 shares
$212.42
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
SVP & Chief Accounting Officer
Holding Value $7.5M 15,720 shares
Last Trade
Feb 25, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$231k 1,080 shares
$213.48
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
SVP & Chief Accounting Officer
Holding Value $7.62M 15,964 shares
Last Trade
Feb 24, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$188k 864 shares
$217.57
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
SVP & Chief Accounting Officer
Holding Value $9.8M 20,539 shares
Last Trade
Feb 18, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$910k 4,295 shares
$211.84
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
SVP & Chief Accounting Officer
Holding Value $10.1M 21,123 shares
Last Trade
Feb 17, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$580k 2,740 shares
$211.75
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
SVP & Chief Accounting Officer
Holding Value $11.5M 24,073 shares
Last Trade
Feb 11, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$315k 1,498 shares
$210.57
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
SVP & Chief Accounting Officer
Holding Value $12.1M 25,361 shares
Last Trade
Feb 10, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$139k 651 shares
$214.16
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
SVP & Chief Accounting Officer
Holding Value $12.4M 26,012 shares
Last Trade
Feb 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.34M 11,080 shares
$211.00
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
SVP & Controller
Holding Value $2.22M 4,656 shares
Last Trade
Aug 06, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$295k 1,078 shares
$273.34
$477.08
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
SVP & Controller
Holding Value $7.64M 16,010 shares
Last Trade
Aug 06, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$295k 1,078 shares
$273.34
$477.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up